APA (7th ed.) Citation

M, S., CT, Z., PD, K., X, L., CS, M., A, U., . . . NL, L. (2019). Cytotoxic synergy between alisertib and carboplatin versus alisertib and irinotecan are inversely dependent on MGMT levels in glioblastoma cells. Journal of neuro-oncology, 143(2), 231. https://doi.org/10.1007/s11060-019-03164-5

Chicago Style (17th ed.) Citation

M, Sak, et al. "Cytotoxic Synergy Between Alisertib and Carboplatin Versus Alisertib and Irinotecan Are Inversely Dependent on MGMT Levels in Glioblastoma Cells." Journal of Neuro-oncology 143, no. 2 (2019): 231. https://doi.org/10.1007/s11060-019-03164-5.

MLA (9th ed.) Citation

M, Sak, et al. "Cytotoxic Synergy Between Alisertib and Carboplatin Versus Alisertib and Irinotecan Are Inversely Dependent on MGMT Levels in Glioblastoma Cells." Journal of Neuro-oncology, vol. 143, no. 2, 2019, p. 231, https://doi.org/10.1007/s11060-019-03164-5.